Literature DB >> 19185983

A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting.

Axel Regeniter1, Jens Kuhle, Matthias Mehling, Helgard Möller, Ulrich Wurster, Heike Freidank, Werner H Siede.   

Abstract

The CNS immune response often leads to characteristic interrelated biochemical changes in cerebrospinal fluid. Multiple analytes, i.e. cell count, cell differential, evaluation of barrier function and intrathecal IgG, IgA and IgM synthesis should be included in basic diagnostic workup. We describe the scientific background, laboratory investigations and characteristic patterns found with basic CSF analysis, based on the recommendations of the German cerebrospinal fluid society. The concept is substantiated by retrospectively analyzing data of 4026 paired CSF/serum samples. 53% of our samples presented with at least one or several combined abnormal findings. An intrathecal IgG, IgA or IgM immunoglobulin response (37%, n=1481) and a blood-CSF barrier dysfunction (37%; n=1473) were most frequent; followed by an elevated leukocyte cell count (25%; n=992). The immunoglobulin response showed an intrathecal production of IgG in 49% (n=731/1481), which was only detectable in isoelectric focusing in 27% (n=200/731). Intrathecal IgM (n=389) and IgA (n=361) synthesis presented with nearly equal frequency of 25% in samples with intrathecal immunoglobulin response. The immunoglobulin pattern showed a solitary one class reaction of IgG, IgA or IgM in 67%, a combined two class reaction of IgG/IgA, IgG/IgM or IgA/IgM synthesis in 16% and a combined three-class reaction of IgG, IgA and IgM in 17%. This approach generates valuable but numerous complex and interrelated biochemical data. We therefore developed a knowledge-based system combined with visual oriented laboratory output to transfer the information more effectively. This often uncovers typical patterns specific for distinct neurological diseases, is well accepted by our medical community documented by a 37% increase in external ordering.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19185983     DOI: 10.1016/j.clineuro.2008.12.004

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  10 in total

1.  Cerebrospinal fluid proteome of patients with acute Lyme disease.

Authors:  Thomas E Angel; Jon M Jacobs; Robert P Smith; Mark S Pasternack; Susan Elias; Marina A Gritsenko; Anil Shukla; Edward C Gilmore; Carol McCarthy; David G Camp; Richard D Smith; H Shaw Warren
Journal:  J Proteome Res       Date:  2012-08-31       Impact factor: 4.466

2.  Ontogeny of inter-alpha inhibitor proteins in ovine brain and somatic tissues.

Authors:  Mariya S Spasova; Grazyna B Sadowska; Steven W Threlkeld; Yow-Pin Lim; Barbara S Stonestreet
Journal:  Exp Biol Med (Maywood)       Date:  2014-06

3.  Metronidazole and hydroxymetronidazole central nervous system distribution: 2. cerebrospinal fluid concentration measurements in patients with external ventricular drain.

Authors:  Denis Frasca; Claire Dahyot-Fizelier; Christophe Adier; Olivier Mimoz; Bertrand Debaene; William Couet; Sandrine Marchand
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

4.  Laboratory testing of extravascular body fluids in Croatia: a survey of the Working group for extravascular body fluids of the Croatian Society of Medical Biochemistry and Laboratory Medicine.

Authors:  Lara Milevoj Kopcinovic; Zeljka Vogrinc; Irena Kocijan; Jelena Culej; Merica Aralica; Anja Jokic; Dragana Antoncic; Marija Bozovic
Journal:  Biochem Med (Zagreb)       Date:  2016-10-15       Impact factor: 2.313

5.  CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease.

Authors:  Julia Remnestål; David Just; Nicholas Mitsios; Claudia Fredolini; Jan Mulder; Jochen M Schwenk; Mathias Uhlén; Kim Kultima; Martin Ingelsson; Lena Kilander; Lars Lannfelt; Per Svenningsson; Bengt Nellgård; Henrik Zetterberg; Kaj Blennow; Peter Nilsson; Anna Häggmark-Månberg
Journal:  Proteomics Clin Appl       Date:  2016-10-10       Impact factor: 3.494

6.  Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on "Chemokine CXCL13 in serum, CSF, and blood-CSF barrier function".

Authors:  Krista D DiSano; Francesca Gilli; Andrew R Pachner
Journal:  Fluids Barriers CNS       Date:  2021-02-25

7.  In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR).

Authors:  Astrid Guldbrandsen; Heidrun Vethe; Yehia Farag; Eystein Oveland; Hilde Garberg; Magnus Berle; Kjell-Morten Myhr; Jill A Opsahl; Harald Barsnes; Frode S Berven
Journal:  Mol Cell Proteomics       Date:  2014-07-18       Impact factor: 5.911

8.  Interactions between Flow Oscillations and Biochemical Parameters in the Cerebrospinal Fluid.

Authors:  Vincent Puy; Jadwiga Zmudka-Attier; Cyrille Capel; Roger Bouzerar; Jean-Marie Serot; Anne-Marie Bourgeois; Jérome Ausseil; Olivier Balédent
Journal:  Front Aging Neurosci       Date:  2016-06-29       Impact factor: 5.750

9.  Combined proteomic and metabolomic analyses of cerebrospinal fluid from mice with ischemic stroke reveals the effects of a Buyang Huanwu decoction in neurodegenerative disease.

Authors:  Wei-Hsiang Hsu; Yuh-Chiang Shen; Young-Ji Shiao; Ching-Hua Kuo; Chung-Kuang Lu; Tai-Yuan Lin; Wei-Chi Ku; Yun-Lian Lin
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

10.  In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease.

Authors:  Zhengwei Chen; Qinying Yu; Qing Yu; Jillian Johnson; Richard Shipman; Xiaofang Zhong; Junfeng Huang; Sanjay Asthana; Cynthia Carlsson; Ozioma Okonkwo; Lingjun Li
Journal:  Mol Cell Proteomics       Date:  2021-04-20       Impact factor: 5.911

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.